- Home
- CUB vs OCGN Comparison
CUB vs OCGN Comparison
Compare CUB & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUB
- OCGN
- Stock Information
- Founded
- CUB 2024
- OCGN 2013
- Country
- CUB United States
- OCGN United States
- Employees
- CUB N/A
- OCGN N/A
- Industry
- CUB
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CUB
- OCGN Health Care
- Exchange
- CUB NYSE
- OCGN Nasdaq
- Market Cap
- CUB 321.1M
- OCGN 283.3M
- IPO Year
- CUB 2024
- OCGN N/A
- Fundamental
- Price
- CUB $10.47
- OCGN $1.07
- Analyst Decision
- CUB
- OCGN Strong Buy
- Analyst Count
- CUB 0
- OCGN 3
- Target Price
- CUB N/A
- OCGN $6.00
- AVG Volume (30 Days)
- CUB 14.0K
- OCGN 3.7M
- Earning Date
- CUB 08-22-2025
- OCGN 08-01-2025
- Dividend Yield
- CUB N/A
- OCGN N/A
- EPS Growth
- CUB N/A
- OCGN N/A
- EPS
- CUB 0.34
- OCGN N/A
- Revenue
- CUB N/A
- OCGN $4,522,000.00
- Revenue This Year
- CUB N/A
- OCGN N/A
- Revenue Next Year
- CUB N/A
- OCGN N/A
- P/E Ratio
- CUB $31.19
- OCGN N/A
- Revenue Growth
- CUB N/A
- OCGN N/A
- 52 Week Low
- CUB $9.96
- OCGN $0.52
- 52 Week High
- CUB $10.61
- OCGN $1.55
- Technical
- Relative Strength Index (RSI)
- CUB N/A
- OCGN 52.81
- Support Level
- CUB N/A
- OCGN $1.01
- Resistance Level
- CUB N/A
- OCGN $1.18
- Average True Range (ATR)
- CUB 0.00
- OCGN 0.08
- MACD
- CUB 0.00
- OCGN -0.01
- Stochastic Oscillator
- CUB 0.00
- OCGN 45.45
About CUB LIONHEART HOLDINGS
Lionheart Holdings is a blank check company.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").